QUCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Quantum Cyber N.V.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.07+0.01 (+0.94%)
Close on Oct 19, 2026
- Market cap
- $19.10M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2018 to 2025
Gross margin
72.6%+47.6 pts over 5 years
Operating margin
-3005.0%−2868.5 pts over 5 years
Net margin
-3018.3%−2899.4 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -39.9% | +0.5% | +1.7% | – | |
| Gross profit | -32.2% | +28.9% | +25.9% | – |
Returns and balance sheet
8 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2018 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | – | -488.3% | |
| Return on assets | – | – | -172.2% | |
| Current ratio | – | 0.27 | 0.90 | |
| Interest coverage | – | -3.8× | -43.2× | |
| Inventory turnover | – | – | 0.5× | |
| Capex to revenue | – | 2.0% | 0.2% | |
| Diluted shares | – | 0M | 6M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Quantum Cyber generated $68.24M from operations and spent $1.98M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$68.24M
Used
$1.98M
Capital expenditure$1.98M100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-3018.3%
×Asset turnover0.06×
×Equity multiplier2.84×
=Return on equity, FY2025-488.3%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -3018.3% | 0.06× | 2.84× | -488.3% |
| FY2024 | -2416.0% | 0.06× | 3.09× | -462.0% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
3of 8 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero-$16.21M
- Cash generatingOperating cash flow above zero-$10.98M
- Return on assets improvedROA up on the prior year-140.2% → -120.1%
- Earnings backed by cashOperating cash flow above net income-$10.98M vs -$16.21M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose1.30 → 0.90
- No dilutionShare count did not rise1M → 6M
- Gross margin improvedGross margin up on the prior year64.31% → 72.58%
- More efficientAsset turnover rose0.06 → 0.04